|
Volumn 46, Issue 1-2, 2004, Pages 199-201
|
Change in human visceral leishmaniasis treatment in Italy;Cambiamento nella terapia della leishmaniosi viscerale umana in Italia: Studio retrospettivo su 630 pazienti
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
AMPHOTERICIN B;
AMPHOTERICIN B CHOLESTEROL SULFATE;
AMPHOTERICIN B LIPID COMPLEX;
ANTIPROTOZOAL AGENT;
LIPOSOME;
MEGLUMINE;
MEGLUMINE ANTIMONIATE;
ORGANOMETALLIC COMPOUND;
ALTERNATIVE MEDICINE;
BONE MARROW;
COMPARATIVE STUDY;
CONFERENCE PAPER;
COST EFFECTIVENESS ANALYSIS;
HOSPITAL;
HUMAN;
IMMUNOCOMPETENCE;
INFORMATION PROCESSING;
ITALY;
MYCOSIS;
NONHUMAN;
SERUM;
TIME SERIES ANALYSIS;
VISCERAL LEISHMANIASIS;
ADULT;
CHILD;
CLINICAL PRACTICE;
CLINICAL TRIAL;
DRUG UTILIZATION;
RETROSPECTIVE STUDY;
REVIEW;
STATISTICS;
TREATMENT OUTCOME;
ADULT;
AMPHOTERICIN B;
ANTIPROTOZOAL AGENTS;
CHILD;
CLINICAL TRIALS;
DRUG UTILIZATION;
HUMANS;
IMMUNOCOMPETENCE;
ITALY;
LEISHMANIASIS, VISCERAL;
LIPOSOMES;
MEGLUMINE;
ORGANOMETALLIC COMPOUNDS;
PHYSICIAN'S PRACTICE PATTERNS;
RETROSPECTIVE STUDIES;
TREATMENT OUTCOME;
|
EID: 4844219939
PISSN: 00482951
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (17)
|
References (6)
|